Clinical Scorecard: Incorporating Elastography Improves Diagnostic Precision of ACR TI-RADS for Assessing Thyroid Nodules
At a Glance
Category
Detail
Condition
Thyroid nodules
Key Mechanisms
Use of strain elastography (SE) and color Doppler ultrasonography (CDUS) to assess tissue stiffness and vascularity, enhancing malignancy risk stratification beyond conventional grayscale ultrasonography in ACR TI-RADS
Target Population
Adult patients (≥18 years) with thyroid nodules ≥10 mm referred for fine-needle aspiration (FNA) per ACR TI-RADS criteria
Care Setting
Endocrinology and Nuclear Medicine Departments in hospital outpatient or diagnostic imaging settings
Key Highlights
Addition of elastography ratio thresholds to ACR TI-RADS criteria significantly reduced unnecessary FNAs from 501 to 260 without missing malignant cases.
Elastography showed excellent discriminative performance in ACR TI-RADS category 3 nodules (Youden index 0.994, AUC 0.994), improving risk stratification in predominantly benign nodules.
Incorporation of demographic and clinical data alongside advanced US techniques can optimize malignancy risk assessment and management decisions.
Guideline-Based Recommendations
Diagnosis
Use ACR TI-RADS as the primary risk stratification tool for thyroid nodules ≥10 mm.
Incorporate strain elastography with specific elastography ratio thresholds (>1.60 for TI-RADS 3, >0.44 for TI-RADS 4, >0.54 for TI-RADS 5) to refine malignancy risk assessment.
Consider color Doppler ultrasonography to evaluate nodule vascularity as an adjunct, recognizing its ongoing investigational status.
Management
Apply elastography criteria to reduce unnecessary fine-needle aspiration biopsies without compromising detection of malignancy.
Exclude patients with elevated calcitonin or autonomously functioning nodules from this protocol.
Integrate clinical and demographic factors, including age, sex, and autoimmune thyroiditis status, into overall risk assessment.
Monitoring & Follow-up
Perform standardized ultrasound evaluations including B-mode, elastography, and vascularity assessments by experienced operators.
Use cytological analysis per Bethesda system for nodules undergoing FNA.
Follow-up with surgical pathology when available to confirm malignancy status.
Risks
Potential for missed malignancies minimized by combined use of elastography thresholds and ACR TI-RADS criteria.
Variability in elastography techniques and lack of standardized protocols may affect reproducibility.
Exclusion of patients with prior thyroid cancer or previously biopsied nodules to avoid confounding.
Patient & Prescribing Data
Adults with thyroid nodules ≥10 mm undergoing evaluation for malignancy risk
Incorporating elastography into imaging protocols can reduce unnecessary invasive procedures (FNA) while maintaining high sensitivity for malignancy detection.
Clinical Best Practices
Use a standardized ultrasound protocol including B-mode, color Doppler, and strain elastography performed by experienced operators.
Apply elastography ratio thresholds specific to ACR TI-RADS categories to guide biopsy decisions.
Collect comprehensive clinical and demographic data to complement imaging findings in risk stratification.
Exclude patients with elevated calcitonin or autonomously functioning nodules from elastography-based risk assessment.
Ensure cytological evaluation follows Bethesda system standards and confirm malignancy with surgical pathology when possible.
